Czech Republic

The first half of 2008 has brought mixed results for pharmaceutical companies operating in Romania. Often considered as a high potential market for investment, it appears that the... 2008-07-31

Czech generics specialist Zentiva has said it expects sales to reach CZK8.9bn for the first half of 2008, a 32% year-on-year (y-o-y) growth. A continuing decline in sales in its key... 2008-07-25

The Czech Republic has seen a rapid expansion in the number of online pharmacies over the last two years, which is one of the factors behind BMI's optimism for market growth of over-the-counter... 2008-07-11

In what is the second deal of its kind in a week, another multinational innovative pharmaceutical company is looking to expand in the generics arena. Following the US$4.6bn takeover... 2008-06-19

US drugmaker Mylan has exercised its option to acquire Merck KGaA's Central and Eastern Europe (CEE) generics business, expanding its European footprint and gaining access to high... 2008-06-03

Czech anticorruption watchdog Transparency International-Czech Republic (TIC) has filed a criminal complaint in the Czech Republic against representatives of Canadian-based pharmaceutical... 2008-05-20

Czech pharmaceutical company Zentiva is developing a generic form of Eli Lilly's erectile dysfunction (ED) drug Viagra (sildenafil) to be sold in its existing markets. Zentiva, the... 2008-05-01

Israeli generics firm Teva is planning to invest US$100mn in one of its facilities in Northern Moravia, in the Czech Republic, with the aim of trebling production there over the next... 2008-03-12

In 2007, Czech drugmaker Zentiva's sales grew by 19% to CZK16.7bn (US$1.03bn), due mainly to the acquisition of Turkish drug firm Eczacibaşi in March 2007 for EUR460mn

With the Czech Republic's new health reforms taking effect in January 2008, pharmacies around the country are reportedly beginning to feel the bite.